Event-Driven Stocks

Traws Pharma, Inc.

TRAWNasdaq

Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs1 good4 warning3 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$2.8M$226,000$226,000$226,000$226,000$231,000
Operating income−$17.9M−$142.4M−$20.3M−$19.6M−$16.5M−$25.0M
Net income$9.2M−$166.5M−$18.9M−$19.0M−$16.2M−$25.2M
Total assets$10.6M$25.0M$22.7M$39.4M$55.5M$20.0M
Total liabilities$11.2M$56.6M$12.0M$11.1M$9.4M$13.8M
Equity−$629,000−$31.6M$10.7M$28.3M$46.1M$6.2M
EPS (diluted)$0.82$-35.21$-22.57$-0.91$-0.96$-2.17
Shares out.5.1M21.0M21.0M20.9M236.6M167.3M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−640.7%
Net margin
328.7%
Return on equity
−1457.9%
Return on assets
86.4%
Return on capital (ROCE)
Liabilities / assets
105.9%
Debt / equity
Book value / share
$-0.12
Revenue growth (YoY)
1134.5%
Net income growth (YoY)

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-209.84distress
Accruals / assets
257.7%high accruals
Piotroski F-Score
6/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
43
/ 100
Profitability 50Growth 100Catalyst 67Earnings quality 0Financial strength 0

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

3 severe4 warning1 good
  • Negative shareholder equity
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Operating losses (negative operating margin)
  • High leverage (liabilities > 70% of assets)
  • Negative operating cash flow
  • High accruals — earnings-quality risk
  • Revenue is growing year-over-year

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

Clinical trials

ClinicalTrials.gov · ongoing · next readout first

Interventional studies led by this company. “Readout” is the trial's primary-completion date — an estimate the sponsor reports, not a guarantee.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 20261.7M1.0+198.4%
Apr 30, 2026560,0361.8+38.1%
Apr 15, 2026405,5992.0-1.5%
Mar 31, 2026411,6378.8-9.9%
Mar 13, 2026456,6634.4-12.2%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)